• Acute Care
    Medicure Focuses On
    Development & Commercialization
    of Cardiovascular Therapeutics

    For the U.S Market
  • Medicure Investments
    medicure is traded
    on TSX Venture (MPH)
    The Company’s primary operating focus is on the sale and marketing of its acute care cardiovascular drug, AGGRASTAT (tirofiban HCI).